Search Results - "Vonderheid, E C"
-
1
Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma
Published in British journal of dermatology (1951) (01-07-2009)“…Summary Background Extracorporeal photopheresis (ECP) is an approved palliative treatment for cutaneous T‐cell lymphoma (CTCL). The THERAKOS™ CELLEX™…”
Get full text
Journal Article -
2
-
3
BCL2 and JUNB abnormalities in primary cutaneous lymphomas
Published in British journal of dermatology (1951) (01-09-2004)“…Summary Background BCL2 is upregulated in nodal and extranodal B‐cell non‐Hodgkin's lymphomas, with a consequent antiapoptotic effect. However, loss of BCL2…”
Get full text
Journal Article -
4
Interleukin-12 Therapy of Cutaneous T-Cell Lymphoma Induces Lesion Regression and Cytotoxic T-Cell Responses
Published in Blood (01-08-1999)“…Progression of cutaneous T-cell lymphoma (CTCL) is associated with profound defects in cell-mediated immunity and depressed production of cytokines, which…”
Get full text
Journal Article -
5
Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis
Published in British journal of dermatology (1951) (01-11-2007)“…Summary Background Serum proteomic analysis is an analytical technique utilizing high‐throughput mass spectrometry (MS) in order to assay thousands of serum…”
Get full text
Journal Article -
6
Activation of Jak/STAT Proteins Involved in Signal Transduction Pathway Mediated by Receptor for Interleukin 2 in Malignant T Lymphocytes Derived from Cutaneous Anaplastic Large T-Cell Lymphoma and Sezary Syndrome
Published in Proceedings of the National Academy of Sciences - PNAS (20-08-1996)“…Signaling through the interleukin 2 receptor (IL-2R) involves phosphorylation of several proteins including Jak3, STAT5, and, in preactivated cells, STAT3. In…”
Get full text
Journal Article -
7
Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma
Published in Journal of the American Academy of Dermatology (01-02-1998)“…Background: The serum concentration of soluble a chain of the interleukin-2 receptor (sIL-2R) correlates with tumor burden in cutaneous T-cell lymphoma (CTCL)…”
Get full text
Journal Article -
8
Radiotherapy for unilesional mycosis fungoides
Published in International journal of radiation oncology, biology, physics (01-09-1998)“…To evaluate the treatment outcome and natural history of patients with the diagnosis of unilesional mycosis fungoides, treated according to a prospective…”
Get more information
Journal Article -
9
Genetic markers associated with progression in early mycosis fungoides
Published in Journal of the European Academy of Dermatology and Venereology (01-11-2014)“…Background Mycosis fungoides (MF) is a rare, but potentially devastating malignancy. It classically presents with cutaneous patches and plaques and can…”
Get full text
Journal Article -
10
Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing
Published in Leukemia research (01-03-2006)“…To understand better T-cell lymphomagenesis, we examined promoter CpG methylation and mRNA expression of closely related genes encoding p16, p15, and p14 tumor…”
Get full text
Journal Article -
11
Aberrant Cytokine Production By Sezary Syndrome Patients: Cytokine Secretion Pattern Resembles Murine Th2 Cells
Published in Journal of investigative dermatology (01-07-1992)“…Sezary syndrome (SzS), the leukemic stage of cutaneous T-cell lymphoma (CTCL), is typically a CD4+ T-cell lympho-proliferative disease characterized by…”
Get full text
Journal Article -
12
Cutaneous T-cell lymphoma in association with silicone breast implants
Published in Journal of the American Academy of Dermatology (01-06-1995)“…Background: Cutaneous T-cell lymphoma (CTCL) is a chronic malignancy of helper T cells with the CD4 phenotype. It occurs less frequently in young women but is…”
Get full text
Journal Article -
13
p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: A study of 12 cases
Published in Journal of cutaneous pathology (01-09-1999)“…The transformation of cutaneous T‐cell lymphoma (t‐CTCL) is an uncommon phenomenon that is associated with histopathologic changes and follows an aggressive…”
Get full text
Journal Article -
14
Fine-needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome)
Published in American journal of clinical pathology (01-06-2000)“…We studied the role of fine-needle aspiration (FNA) in the evaluation of lymphadenopathy associated with cutaneous T-cell lymphoma (CTCL) in 11 patients with…”
Get full text
Journal Article -
15
Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes
Published in Journal of the American Academy of Dermatology (01-04-1990)“…We identified nine patients with cutaneous T cell lymphoma in whom the neoplastic cells expressed the CD8 (T8) suppressor T cell phenotype instead of the more…”
Get more information
Journal Article -
16
Localized cutaneous amyloidosis associated with mycosis fungoides
Published in Journal of the American Academy of Dermatology (01-07-1997)Get full text
Journal Article -
17
Sarcoidal tissue reaction in Sézary syndrome
Published in Journal of the American Academy of Dermatology (01-08-2000)“…Sézary syndrome (SS) is an erythrodermic and leukemic variant of cutaneous T-cell lymphoma (CTCL). Occasionally, the histology of CTCL exhibits evidence of a…”
Get full text
Journal Article -
18
Autologous bone marrow transplantation for advanced stage mycosis fungoides
Published in Bone marrow transplantation (Basingstoke) (01-02-1991)“…Patients with advanced stage cutaneous T cell lymphoma (CTCL) have a median survival of 2-5 years with no currently available curative therapy. This limited…”
Get more information
Journal Article -
19
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma
Published in The Journal of experimental medicine (02-06-2003)“…We have used cDNA arrays to investigate gene expression patterns in peripheral blood mononuclear cells from patients with leukemic forms of cutaneous T cell…”
Get full text
Journal Article -
20
Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma
Published in Journal of the American Academy of Dermatology (01-03-1989)“…Complete responses lasting from 4 to 14 years were documented in 65 of 331 (20%) patients with cutaneous T cell lymphoma treated with topical mechlorethamine…”
Get more information
Journal Article